VR Adviser, LLC Q2 2023 Filing
Filed August 11, 2023
Portfolio Value
$625.4B
Holdings
30
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (30 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VRDNVIRIDIAN THERAPEUTICS INC | 3,082,622 | $73K | 0.00% | |
| 2 | COGTCOGENT BIOSCIENCES INC | 4,684,132 | $55K | 0.00% | |
| 3 | FDMT4D MOLECULAR THERAPEUTICS IN | 3,000,000 | $54K | 0.00% | |
| 4 | ELVNENLIVEN THERAPEUTICS INC | 2,230,127 | $45K | 0.00% | |
| 5 | MRUSMERUS N V | 1,726,214 | $45K | 0.00% | |
| 6 | GHRSGH RESEARCH PLC | 3,517,125 | $41K | 0.00% | |
| 7 | —AMBRX BIOPHARMA INC | 2,484,960 | $40K | 0.00% | |
| 8 | KALVKALVISTA PHARMACEUTICALS INC | 2,916,667 | $26K | 0.00% | |
| 9 | TERNTERNS PHARMACEUTICALS INC | 2,972,869 | $26K | 0.00% | |
| 10 | CABACABALETTA BIO INC | 1,973,251 | $25K | 0.00% | |
| 11 | DYNDYNE THERAPEUTICS INC | 2,173,913 | $24K | 0.00% | |
| 12 | CELCCELCUITY INC | 2,105,386 | $23K | 0.00% | |
| 13 | YB4PSAVARA INC | 6,351,531 | $20K | 0.00% | |
| 14 | PHVSPHARVARIS N V | 1,326,200 | $20K | 0.00% | |
| 15 | RYTMRHYTHM PHARMACEUTICALS INC | 1,090,000 | $17K | 0.00% | |
| 16 | ORICORIC PHARMACEUTICALS INC | 2,142,856 | $16K | 0.00% | |
| 17 | ACRSACLARIS THERAPEUTICS INC | 1,040,754 | $10K | 0.00% | |
| 18 | TRVITREVI THERAPEUTICS INC | 3,422,397 | $8K | 0.00% | |
| 19 | —THESEUS PHARMACEUTICALS INC | 770,000 | $7K | 0.00% | |
| 20 | APLTAPPLIED THERAPEUTICS INC | 5,658,034 | $7K | 0.00% | |
| 21 | PRAXPRAXIS PRECISION MEDICINES I | 5,304,410 | $6K | 0.00% | |
| 22 | MISTMILESTONE PHARMACEUTICALS IN | 2,208,812 | $6K | 0.00% | |
| 23 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 3,886,246 | $6K | 0.00% | |
| 24 | PLRXPLIANT THERAPEUTICS INC | 288,949 | $5K | 0.00% | |
| 25 | LYRALYRA THERAPEUTICS INC | 924,170 | $3K | 0.00% | |
| 26 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 6,343,221 | $2K | 0.00% | |
| 27 | BDTXBLACK DIAMOND THERAPEUTICS I | 353,629 | $1K | 0.00% | |
| 28 | RLYBRALLYBIO CORP | 268,532 | $1K | 0.00% | |
| 29 | —AVALO THERAPEUTICS INC | 1,250,000 | $0 | 0.00% | |
| 30 | —AFFIMED N V | 1,428,571 | $0 | 0.00% |